Ad
related to: Comirnaty and Pfizer-BioNTech COVID-19 Vaccine
Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 5 days ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown...
Benzinga· 6 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 7 days agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 7 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 4 days agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer-...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 5 days agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 14 hours agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 6 days agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Rival Covid-19 jab developers face off in High Court patent trial
Press Association News via AOL· 7 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
